FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380421954> ?p ?o ?g. }

• W4380421954 abstract "Abstract Background and Objectives Dual renin-angiotensin-aldosterone system (RAAS) blockade involves dual therapy with a combination of angiotensin-converting enzyme inhibitors (ACEis), angiotensin receptor blockers (ARBs), direct renin inhibitors (DRIs) or mineralocorticoid receptor antagonists (MRAs). It is hypothesized that dual RAAS blockade would result in a more complete inhibition of the RAAS cascade. However, large clinical trials on dual RAAS inhibition have shown increased risk of acute kidney injury (AKI) and hyperkalemia without additional benefit on mortality, cardiovascular events, or CKD progression compared to RAAS inhibitor monotherapy in patients with diabetic kidney disease (DKD). The development of newer, more selective non-steroidal MRAs as cardiorenal protective therapies has created a new opportunity for dual RAAS inhibition. We conducted a systematic review and meta-analysis of the risks of AKI and hyperkalemia with dual RAAS blockade in patients with DKD. Design, setting, participants, & measurements This is a systematic review and meta-analysis of the randomized controlled trials (RCT) published from 2006 to May 30, 2022. Study population included adult patients with DKD receiving dual RAAS blockade. A total of 31 RCTs and 33 048 patients were included in the systematic review. Pooled risk ratios (RRs) and 95% confidence intervals (CIs) were calculated using random effects. Results There were 208 AKI events in 2690 patients on ACEi + ARB versus 170 in 4264 patients with ACEi or ARB monotherapy (pooled RR 1.48, 95% CI: 1.23–1.39). There were 304 hyperkalemia events in 2818 patients on ACEi + ARB versus 208 in 4396 patients with ACEi or ARB monotherapy (pooled RR 1.97, 95% CI: 1.32–2.94). A non-steroidal MRA + ACEi or ARB showed no increase in the risk of AKI (pooled RR 0.97, 95% CI: 0.81–1.16) compared to ACEi or ARB monotherapy but had a 2-fold higher risk of hyperkalemia with 953 events in 7837 patients in dual therapy versus 454 events in 6895 patients in monotherapy (pooled RR 2.05, 95% CI: 1.84–2.28). A steroidal MRA + ACEi or ARB had a 5-fold higher risk of hyperkalemia with 28 events in 245 at risk in dual therapy versus 5 events in 248 at risk in monotherapy (pooled RR 5.42 95% CI: 2.15–13.67). Conclusion Dual therapy with RAASi is associated with an increased risk of AKI and hyperkalemia compared to RAASi monotherapy. Conversely, dual therapy with RAAS inhibitors and non-steroidal MRAs have no additional risk of AKI but a similar risk of hyperkalemia, which is lower than dual therapy with RAAS inhibitors and steroidal MRAs." @default.
• W4380421954 created "2023-06-14" @default.
• W4380421954 creator A5025365385 @default.
• W4380421954 creator A5025975112 @default.
• W4380421954 creator A5032044327 @default.
• W4380421954 creator A5040257052 @default.
• W4380421954 creator A5046670582 @default.
• W4380421954 creator A5089363439 @default.
• W4380421954 creator A5089508740 @default.
• W4380421954 creator A5092150307 @default.
• W4380421954 date "2023-06-12" @default.
• W4380421954 modified "2023-10-09" @default.
• W4380421954 title "The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis" @default.
• W4380421954 doi "https://doi.org/10.1093/ndt/gfad101" @default.
• W4380421954 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37309038" @default.
• W4380421954 hasPublicationYear "2023" @default.
• W4380421954 type Work @default.
• W4380421954 citedByCount "1" @default.
• W4380421954 crossrefType "journal-article" @default.
• W4380421954 hasAuthorship W4380421954A5025365385 @default.
• W4380421954 hasAuthorship W4380421954A5025975112 @default.
• W4380421954 hasAuthorship W4380421954A5032044327 @default.
• W4380421954 hasAuthorship W4380421954A5040257052 @default.
• W4380421954 hasAuthorship W4380421954A5046670582 @default.
• W4380421954 hasAuthorship W4380421954A5089363439 @default.
• W4380421954 hasAuthorship W4380421954A5089508740 @default.
• W4380421954 hasAuthorship W4380421954A5092150307 @default.
• W4380421954 hasBestOaLocation W43804219541 @default.
• W4380421954 hasConcept C126322002 @default.
• W4380421954 hasConcept C168563851 @default.
• W4380421954 hasConcept C170493617 @default.
• W4380421954 hasConcept C189135053 @default.
• W4380421954 hasConcept C2778468042 @default.
• W4380421954 hasConcept C2778525890 @default.
• W4380421954 hasConcept C2778653478 @default.
• W4380421954 hasConcept C2780243291 @default.
• W4380421954 hasConcept C2780472472 @default.
• W4380421954 hasConcept C71924100 @default.
• W4380421954 hasConceptScore W4380421954C126322002 @default.
• W4380421954 hasConceptScore W4380421954C168563851 @default.
• W4380421954 hasConceptScore W4380421954C170493617 @default.
• W4380421954 hasConceptScore W4380421954C189135053 @default.
• W4380421954 hasConceptScore W4380421954C2778468042 @default.
• W4380421954 hasConceptScore W4380421954C2778525890 @default.
• W4380421954 hasConceptScore W4380421954C2778653478 @default.
• W4380421954 hasConceptScore W4380421954C2780243291 @default.
• W4380421954 hasConceptScore W4380421954C2780472472 @default.
• W4380421954 hasConceptScore W4380421954C71924100 @default.
• W4380421954 hasLocation W43804219541 @default.
• W4380421954 hasLocation W43804219542 @default.
• W4380421954 hasOpenAccess W4380421954 @default.
• W4380421954 hasPrimaryLocation W43804219541 @default.
• W4380421954 hasRelatedWork W1979734761 @default.
• W4380421954 hasRelatedWork W2002955169 @default.
• W4380421954 hasRelatedWork W2007323322 @default.
• W4380421954 hasRelatedWork W2143602929 @default.
• W4380421954 hasRelatedWork W2168712739 @default.
• W4380421954 hasRelatedWork W2968569547 @default.
• W4380421954 hasRelatedWork W3033258737 @default.
• W4380421954 hasRelatedWork W3034022740 @default.
• W4380421954 hasRelatedWork W3035884590 @default.
• W4380421954 hasRelatedWork W4245599485 @default.
• W4380421954 isParatext "false" @default.
• W4380421954 isRetracted "false" @default.
• W4380421954 workType "article" @default.